Cerebras stock falls on earnings disappointment despite guidance raise

Cerebras Systems (NASDAQ:CBRS) shares fell about 11% after Q2 revenue missed estimates despite raised guidance. Q2 revenue was $180.1M vs $194M expected, with gross margin at 14% vs 26.3%. Core revenue was $209.9M. Full-year core revenue guidance was raised to $880M-$890M and core gross margin to 41%-43%.

Original reporting
Published Aug 13, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 4:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cerebras stock falls on earnings disappointment despite guidance raise — source image
Decision brief

The 30-second read

$CBRSBearishMed
01

Why it matters

Near-term execution concerns (hardware revenue decline, gross margin miss) appear to dominate the stock reaction, even as longer-term targets improve. The next catalyst is the Supernova event tied to WSE-4 and potential customer/partner announcements.

02

Market read

This is a guidance-up, execution-disappointing earnings reaction, with traders likely to reprice near-term revenue and margin durability into the next event.

03

What to watch

Hardware revenue fell 23% YoY and management attributed it to customer data center capacity limits; traders may need to separate demand constraints from product competitiveness and watch for Supernova customer/partner updates.

Relevance 8/10Novelty 6/10Timing: post-earnings, ahead of next week's Supernova event

Background

Cerebras reported Q2 results with a revenue miss and margin disappointment, while raising full-year and Q3 core revenue and margin guidance.

Company-level read

Ticker impact

$CBRSBearishHigh confidence
Context

Cerebras shares fell 11% after Q2 revenue missed estimates and gross margin came in far below expectations, despite raised full-year guidance.

Expected impact

Bearish near-term bias, with downside risk until hardware revenue stabilization or Supernova catalysts translate guidance into execution.

Evidence & confidence

The article cites a revenue miss ($180.1M vs $194M), gross margin miss (14% vs 26.3%), and a sequential hardware decline, which typically outweighs guidance raises for the next few sessions.

Market effects

Highlights ongoing AI chip hardware-to-revenue conversion friction and data center capacity constraints, relevant to AI infrastructure supply chains.

No specific regional market linkage beyond US-listed semiconductor/AI sentiment.

Mentions TSMC wafer supply and sales-cycle timing, underscoring global manufacturing-to-demand translation risk.

Counterpoint

The guidance raise and core gross margin strength (core gross margin 41% up 940 bps) suggest the market may be over-penalizing a temporary hardware timing issue.

Key entities

  • Cerebras Systems Inc

    AI chipmaker whose Q2 revenue and gross margin missed estimates and whose guidance was raised.

  • TSMC

    Cerebras referenced securing incremental wafer supply from TSMC, though revenue conversion takes time.

  • Wedbush

    Attributed the selloff to elevated expectations and flagged Supernova as a more likely catalyst than the quarterly print.

Related articles

$CBRSMedAI 8/10

Why Cerebras Systems Stock Just Sank

Cerebras Systems (CBRS) shares fell about 11.9% on Thursday after its Q2 report, which came in below Wall Street expectations. The company posted a net loss of $2.98 per share on revenue of $180.11 million, with revenue about $13.4 million under forecasts. It raised full-year sales and margin targets.

$CBRSMed

Cerebras Stock Slumps After Earnings -- Analysts See 'Buying Opportunity'

Cerebras Systems (CBRS) shares dropped after its Q2 results. The company reported $180.1M revenue, up over 70% YoY, with an adjusted loss of $6.91M versus about $41M expected, and a net loss of $450.5M. It raised FY2026 core revenue guidance to $880M-$890M and Q3 to $214M-$216M. Analysts kept bullish stances, raising price targets (Wedbush to $290, Morgan Stanley to $279) despite the selloff.

$CBRSMedAI 8/10

Cerebras Systems’ Stock Falls 17% On Mixed Financial Results

Cerebras Systems (CBRS) shares fell 17% after its second earnings report as a public company. The company posted EPS loss of -$0.05 vs -$0.17 expected, but revenue was $180M vs $194M forecast. Net loss was $450.5M. It guided current-quarter revenue to $214M-$216M and full-year to $880M-$890M. Cerebras cited $25.4B backlog.

$CBRSMedAI 8/10

Cerebras Raised Guidance but Still Lost a Fifth of Its Value

Cerebras Systems (CBRS) shares fell premarket after Q2 GAAP revenue of $180.1M missed the $194M consensus. The company reported $209.9M core revenue, excluding pass-through revenue and adding back warrant amortization. Cloud and other services rose to $126.0M, while hardware fell to $54.1M. GAAP net loss was $450.5M ($2.98/share). Full-year core guidance increased to $880M-$890M.